Bristol-Myers Q2 Sales Fall, Will Focus on Cancer Drugs - Presented by: The Aol. On Network

Bristol-Myers Squibb's murky earnings report reveals a company still in flux. Earnings were slightly above analyst estimates at 48 cents a share. The company's revenue came in at $3.9 billion, down 4 percent from the same quarter last year. The sales decline is a result of the company selling its stake in a diabetes alliance with AstraZeneca.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 15.15 0.28 ▼ 1.81%
PBR $ 6.01 0.39 ▼ 6.09%
AAPL $ 117.16 1.74 ▼ 1.46%
MSFT $ 40.40 1.61 ▼ 3.83%
TVIX $ 3.54 0.55 ▲ 18.39%
T $ 32.92 0.04 ▼ 0.12%
GE $ 23.89 0.19 ▼ 0.79%
SIRI $ 3.55 0.04 ▼ 1.11%

As of 1/30/2015, 04:15 PM
More Most Active